-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Corbus Pharmaceuticals Holdings, Inc. annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q2 2018 to Q3 2022.
- Corbus Pharmaceuticals Holdings, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $0.000, a 100% decline from 2021.
- Corbus Pharmaceuticals Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $882K, a 77.6% decline from 2020.
- Corbus Pharmaceuticals Holdings, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $3.94M, a 89.1% decline from 2019.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)